Asia-pacific Botulinum Toxin Market 2023-2030

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $1,500	128 Pages	Triton Market Research	August, 2023	TRTN18135562

Best Price Guarantee
Price	from $1,500
Length	128 Pages
Publisher	Triton Market Research
Published Date	August, 2023
SKU	TRTN18135562

Asia-pacific Botulinum Toxin Market 2023-2030

Market Outlook

Triton’s research report on the Asia-Pacific botulinum toxin market infers that the market is set to advance at a CAGR of 10.88% during the 2023-2030 forecast period. India, China, Japan, Australia & New Zealand, South Korea, ASEAN countries, and Rest of Asia-Pacific are included in the region’s report.

The growing prevalence of migraine in India is expected to elevate the demand for novel therapies, including botulinum toxin. Other than this, as per estimates, around 70,000 botulinum toxin aesthetic procedures were carried out in 2019. This rise in cosmetic treatments is attributed to decreasing healthcare expenses and a growing preference for facial enhancements. These factors are thus expected to boost the expansion of the botulinum toxin market.

South Korea ranks as the eighth-largest global market for cosmetic procedures, boasting the highest number of procedures per person. According to the International Society of Aesthetic Plastic Surgery (ISAPS), the country’s cosmetic surgery sector comprises 2,000 plastic surgery clinics, generating an approximate revenue of around $10 billion. Noteworthy factors driving the studied market include an upsurge in medical tourism, heightened public awareness of cosmetic surgery, easy access to advanced products, a growing elderly population, and a prevalence of beauty-focused individuals.
Competitive Outlook
The well-known companies in the botulinum toxin market include Daewoong Pharmaceutical Co Ltd, Galderma SA, Lanzhou Institute of Biological Products Co Ltd, Ipsen Pharma, Hugel Inc, and Candela Medical Corporation.

1. Asia-pacific Botulinum Toxin Market - Summary
2. Industry Outlook: 2.1. Impact Analysis On The Botulinum Toxin Market; 2.1.1. Covid-19 Impact; 2.2. Key Insights; 2.2.1. Growing Demand For Non-invasive Cosmetic Procedures; 2.2.2. Surge In Demand For Botulinum Toxin Among Millennials And Gen-z; 2.3. Porter’s Five Forces Analysis; 2.3.1. Threat Of New Entrants; 2.3.2. Threat Of Substitutes; 2.3.3. Bargaining Power Of Buyers; 2.3.4. Bargaining Power Of Suppliers; 2.3.5. Threat Of Competitive Rivalry; 2.4. Regulatory Framework; 2.5. Key Market Strategies; 2.5.1. Product Launches; 2.5.2. Collaborations; 2.5.3. Business Expansions & Divestitures; 2.5.4. Acquisitions; 2.6. Market Drivers; 2.6.1. Surge In Demand For Aesthetic Procedures; 2.6.2. Rise In Geriatric Population; 2.7. Market Challenges; 2.7.1. Limited Reimbursement Policies Supporting Cosmetic Procedures; 2.7.2. Adverse Effects Of Botulinum Toxin; 2.7.3. Emerging Problem Of Botulinum Toxin Type A Resistance; 2.8. Market Opportunities; 2.8.1. Expansion Of Botulinum Toxin Into Therapeutic Applications; 2.8.2. Rising Medical Tourism; 2.9. Analyst Perspective
3. Asia-pacific Botulinum Toxin Market Outlook - By Product Type: 3.1. Type A Botulinum Toxin; 3.2. Type B Botulinum Toxin
4. Asia-pacific Botulinum Toxin Market Outlook - By Gender: 4.1. Women; 4.2. Men
5. Asia-pacific Botulinum Toxin Market Outlook - By Application: 5.1. Aesthetic; 5.1.1. Crow’s Feet; 5.1.2. Forehead Lines; 5.1.3. Frown Lines/Glabellar; 5.1.4. Square Jaw/Masseter; 5.1.5. Other Aesthetic Applications; 5.2. Medical; 5.2.1. Chronic Migraine; 5.2.2. Muscle Spasm; 5.2.3. Overactive Bladder; 5.2.4. Hyperhidrosis; 5.2.5. Other Medical Applications
6. Asia-pacific Botulinum Toxin Market Outlook - By End-user: 6.1. Specialty And Dermatology Clinics; 6.2. Hospitals And Clinics; 6.3. Other End-users
7. Asia-pacific Botulinum Toxin Market – By Country Outlook: 7.1. Asia-pacific; 7.1.1. Market By Product Type; 7.1.2. Market By Gender; 7.1.3. Market By Application; 7.1.3.1. Market By Aesthetic; 7.1.3.2. Market By Medical; 7.1.4. Market By End-user; 7.1.5. Country Analysis; 7.1.5.1. China; 7.1.5.1.1. China Botulinum Toxin Market Forecast & Prospects; 7.1.5.2. Japan; 7.1.5.2.1. Japan Botulinum Toxin Market Forecast & Prospects; 7.1.5.3. India; 7.1.5.3.1. India Botulinum Toxin Market Forecast & Prospects; 7.1.5.4. South Korea; 7.1.5.4.1. South Korea Botulinum Toxin Market Forecast & Prospects; 7.1.5.5. Asean Countries; 7.1.5.5.1. Asean Countries Botulinum Toxin Market Forecast & Prospects; 7.1.5.6. Australia & New Zealand; 7.1.5.6.1. Australia & New Zealand Botulinum Toxin Market Forecast & Prospects; 7.1.5.7. Rest Of Asia-pacific; 7.1.5.7.1. Rest Of Asia-pacific Botulinum Toxin Market Forecast & Prospects
8. Competitive Landscape: 8.1. Abbvie Inc; 8.1.1. Overview; 8.1.2. Product Portfolio; 8.1.3. Key Strengths; 8.1.4. Key Challenges; 8.2. Evolus Inc; 8.2.1. Overview; 8.2.2. Product Portfolio; 8.2.3. Key Strengths; 8.2.4. Key Challenges; 8.3. Medytox Inc; 8.3.1. Overview; 8.3.2. Product Portfolio; 8.3.3. Key Strengths; 8.3.4. Key Challenges; 8.4. Lanzhou Institute Of Biological Products Co Ltd; 8.4.1. Overview; 8.4.2. Product Portfolio; 8.4.3. Key Strengths; 8.4.4. Key Challenges; 8.5. Daewoong Pharmaceutical Co Ltd; 8.5.1. Overview; 8.5.2. Product Portfolio; 8.5.3. Key Strengths; 8.5.4. Key Challenges; 8.6. Galderma Sa; 8.6.1. Overview; 8.6.2. Product Portfolio; 8.6.3. Key Strengths; 8.6.4. Key Challenges; 8.7. Ipsen Pharma; 8.7.1. Overview; 8.7.2. Product Portfolio; 8.7.3. Key Strengths; 8.7.4. Key Challenges; 8.8. Hugel Inc; 8.8.1. Overview; 8.8.2. Product Portfolio; 8.8.3. Key Strengths; 8.8.4. Key Challenges; 8.9. Candela Medical Corporation; 8.9.1. Overview; 8.9.2. Product Portfolio; 8.9.3. Key Strengths; 8.9.4. Key Challenges; 8.10. Merz Pharma Gmbh & Co Kgaa; 8.10.1. Overview; 8.10.2. Product Portfolio; 8.10.3. Key Strengths; 8.10.4. Key Challenges; 8.11. Revance Therapeutics Inc; 8.11.1. Overview; 8.11.2. Product Portfolio; 8.12. Us Worldmeds Llc; 8.12.1. Overview; 8.12.2. Product Portfolio
9. Research Methodology & Scope: 9.1. Research Scope & Deliverables; 9.2. Sources Of Data; 9.3. Research Methodology
List Of Tables: Table 1: Asia-pacific Botulinum Toxin Market, By Country Outlook, 2023-2030 (In $ Million); Table 2: Asia-pacific Regulatory Framework For Botulinum Toxin; Table 3: List Of Product Launches; Table 4: List Of Collaborations; Table 5: List Of Business Expansions & Divestitures; Table 6: List Of Acquisitions; Table 7: Example Of Commercially Available Botulinum Toxin Type A For Aesthetic Procedures; Table 8: Asia-pacific Botulinum Toxin Market, By Product Type, 2023-2030 (In $ Million); Table 9: Asia-pacific Botulinum Toxin Market, By Gender, 2023-2030 (In $ Million); Table 10: Asia-pacific Botulinum Toxin Market, By Application, 2023-2030 (In $ Million); Table 11: Asia-pacific Botulinum Toxin Market, By Aesthetic, 2023-2030 (In $ Million); Table 12: Asia-pacific Botulinum Toxin Market, By Medical, 2023-2030 (In $ Million); Table 13: Asia-pacific Botulinum Toxin Market, By End-user, 2023-2030 (In $ Million); Table 14: Asia-pacific Botulinum Toxin Market, By Country Outlook, 2023-2030 (In $ Million)
List Of Figures: Figure 1: Asia-pacific Botulinum Toxin Market, By Product Type, 2022 & 2030 (In %); Figure 2: Asia-pacific Botulinum Toxin Market, By Type A Botulinum Toxin, 2023-2030 (In $ Million); Figure 3: Asia-pacific Botulinum Toxin Market, By Type B Botulinum Toxin, 2023-2030 (In $ Million); Figure 4: Asia-pacific Botulinum Toxin Market, By Gender, 2022 & 2030 (In %); Figure 5: Asia-pacific Botulinum Toxin Market, By Women, 2023-2030 (In $ Million); Figure 6: Asia-pacific Botulinum Toxin Market, By Men, 2023-2030 (In $ Million); Figure 7: Asia-pacific Botulinum Toxin Market, By Application, 2022 & 2030 (In %); Figure 8: Asia-pacific Botulinum Toxin Market, By Aesthetic, 2023-2030 (In $ Million); Figure 9: Asia-pacific Botulinum Toxin Market, By Aesthetic, 2022 & 2030 (In %); Figure 10: Asia-pacific Botulinum Toxin Market, By Crow’s Feet, 2023-2030 (In $ Million); Figure 11: Asia-pacific Botulinum Toxin Market, By Forehead Lines, 2023-2030 (In $ Million); Figure 12: Asia-pacific Botulinum Toxin Market, By Frown Lines/Glabellar, 2023-2030 (In $ Million); Figure 13: Asia-pacific Botulinum Toxin Market, By Square Jaw/Masseter, 2023-2030 (In $ Million); Figure 14: Asia-pacific Botulinum Toxin Market, By Other Aesthetic Applications, 2023-2030 (In $ Million); Figure 15: Asia-pacific Botulinum Toxin Market, By Medical, 2023-2030 (In $ Million); Figure 16: Asia-pacific Botulinum Toxin Market, By Medical, 2022 & 2030 (In %); Figure 17: Asia-pacific Botulinum Toxin Market, By Chronic Migraine, 2023-2030 (In $ Million); Figure 18: Asia-pacific Botulinum Toxin Market, By Muscle Spasm, 2023-2030 (In $ Million); Figure 19: Asia-pacific Botulinum Toxin Market, By Overactive Bladder, 2023-2030 (In $ Million); Figure 20: Asia-pacific Botulinum Toxin Market, By Hyperhidrosis, 2023-2030 (In $ Million); Figure 21: Asia-pacific Botulinum Toxin Market, By Other Medical Applications, 2023-2030 (In $ Million); Figure 22: Asia-pacific Botulinum Toxin Market, By End-user, 2022 & 2030 (In %); Figure 23: Asia-pacific Botulinum Toxin Market, By Specialty And Dermatology Clinics, 2023-2030 (In $ Million); Figure 24: Asia-pacific Botulinum Toxin Market, By Hospitals And Clinics, 2023-2030 (In $ Million); Figure 25: Asia-pacific Botulinum Toxin Market, By Other End-users, 2023-2030 (In $ Million); Figure 26: Asia-pacific Botulinum Toxin Market, By Country Outlook, 2022 & 2030 (In %); Figure 27: China Botulinum Toxin Market 2023-2030 (In $ Million); Figure 28: Japan Botulinum Toxin Market 2023-2030 (In $ Million); Figure 29: India Botulinum Toxin Market 2023-2030 (In $ Million); Figure 30: South Korea Botulinum Toxin Market 2023-2030 (In $ Million); Figure 31: Asean Countries Botulinum Toxin Market 2023-2030 (In $ Million); Figure 32: Australia & New Zealand Botulinum Toxin Market 2023-2030 (In $ Million); Figure 33: Rest Of Asia-pacific Botulinum Toxin Market 2023-2030 (In $ Million)